caffeine has been researched along with Multiple System Atrophy in 1 studies
Multiple System Atrophy: A syndrome complex composed of three conditions which represent clinical variants of the same disease process: STRIATONIGRAL DEGENERATION; SHY-DRAGER SYNDROME; and the sporadic form of OLIVOPONTOCEREBELLAR ATROPHIES. Clinical features include autonomic, cerebellar, and basal ganglia dysfunction. Pathologic examination reveals atrophy of the basal ganglia, cerebellum, pons, and medulla, with prominent loss of autonomic neurons in the brain stem and spinal cord. (From Adams et al., Principles of Neurology, 6th ed, p1076; Baillieres Clin Neurol 1997 Apr;6(1):187-204; Med Clin North Am 1999 Mar;83(2):381-92)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this study was to determine comprehensive metabolic changes of caffeine in the serum of patients with parkinsonian disorders including Parkinson's disease (PD), progressive supranuclear palsy (PSP), and multiple system atrophy (MSA) and to compare this with healthy control serum." | 7.96 | Shared Metabolic Profile of Caffeine in Parkinsonian Disorders. ( Daida, K; Fujimaki, M; Funayama, M; Hatano, T; Hattori, N; Imamichi, Y; Ishiguro, Y; Ishikawa, KI; Li, Y; Mori, A; Nanmo, H; Nojiri, S; Oji, Y; Okuzumi, A; Saiki, S; Takeshige-Amano, H; Tsunemi, T; Ueno, SI, 2020) |
| "The objective of this study was to determine comprehensive metabolic changes of caffeine in the serum of patients with parkinsonian disorders including Parkinson's disease (PD), progressive supranuclear palsy (PSP), and multiple system atrophy (MSA) and to compare this with healthy control serum." | 3.96 | Shared Metabolic Profile of Caffeine in Parkinsonian Disorders. ( Daida, K; Fujimaki, M; Funayama, M; Hatano, T; Hattori, N; Imamichi, Y; Ishiguro, Y; Ishikawa, KI; Li, Y; Mori, A; Nanmo, H; Nojiri, S; Oji, Y; Okuzumi, A; Saiki, S; Takeshige-Amano, H; Tsunemi, T; Ueno, SI, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takeshige-Amano, H | 1 |
| Saiki, S | 1 |
| Fujimaki, M | 1 |
| Ueno, SI | 1 |
| Li, Y | 1 |
| Hatano, T | 1 |
| Ishikawa, KI | 1 |
| Oji, Y | 1 |
| Mori, A | 1 |
| Okuzumi, A | 1 |
| Tsunemi, T | 1 |
| Daida, K | 1 |
| Ishiguro, Y | 1 |
| Imamichi, Y | 1 |
| Nanmo, H | 1 |
| Nojiri, S | 1 |
| Funayama, M | 1 |
| Hattori, N | 1 |
1 other study available for caffeine and Multiple System Atrophy
| Article | Year |
|---|---|
Shared Metabolic Profile of Caffeine in Parkinsonian Disorders.
Topics: Caffeine; Humans; Metabolome; Multiple System Atrophy; Parkinsonian Disorders; Supranuclear Palsy, P | 2020 |